Dr. Afshin Sam, MD

Dr. Sam practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Sam's NPI, 1588836084, was assigned on March 25, 2008. Dr. Sam graduated from Iran University of Medical Sciences in 2000. Dr. Sam's California license number on file is C175062.

Dr. Sam's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Sam's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Sam to 1 more other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sam practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Sam's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Sam is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sam's licenses on file in 7 states: California, Colorado, Nevada, Nebraska, Arizona, Wyoming and Connecticut.

CMS data shows 879 Medicare services from Dr. Sam across 18 procedure codes in 2024, for 405 Medicare patients. Medicare paid $78,783 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 405 Medicare patients who saw Dr. Sam in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 37% are also on Medicaid. Their average risk score is 3.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sam's median patient age at 68, with 54% women.

In 2024, Dr. Sam wrote 367 Medicare Part D claims for 76 patients. 63% of them were for generic drugs. CMS names the drug for 291 of them, across 12 drugs with 11 or more claims each, at $48,497 in total drug cost. In 2023, CMS named 279 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Sam for performance year 2024, reported as part of a group. Dr. Sam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sam as offering telehealth.

Dmand AI links 11 papers to Dr. Sam, published from 2010 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Asthma, Pulmonary Disease, Chronic Obstructive and Pulmonary Embolism. Dr. Sam has published most often in Chest. Dr. Sam's most frequent co-authors are James Lee Knepler, MD, Billie Ann Bixby, MD and Elaine Ann Cristan, MD.

Dmand AI links Dr. Sam to 1 clinical trial. Conditions studied include Asthma and Respiratory Hypersensitivity.

CMS Open Payments shows 48 general payments to Dr. Sam from 10 drug and device companies from 2016 to 2025. Education make up the largest share, 37% of the total. Intuitive Surgical, Inc. paid the most, $4,289.

Dr. Sam graduated from Iran University of Medical Sciences in 2000.

Dr. Sam is in network with 14 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.